
Sumit Bhatnagar, a PhD student in chemical engineering, maintains samples of cancerous cells for use in the development of a pill that could help screen for breast cancer. Tumors are targeted by a molecule that carries a fluorescent imaging agent in order to make earlier and more accurate breast cancer diagnoses. Photo: Evan Dougherty, Michigan Engineering
As many as one in three women treated for breast cancer undergo unnecessary procedures, but a new method for diagnosing it could do a better job distinguishing between benign and aggressive tumors.
Researchers at the University of Michigan are developing a pill that makes tumors light up when exposed to infrared light, and they have demonstrated that the concept works in mice.
Mammography is an imprecise tool. About a third of breast cancer patients treated with surgery or chemotherapy have tumors that are benign or so slow-growing that they would never have become life-threatening, according to a study out of Denmark last year. In other women, dense breast tissue hides the presence of lumps and results in deaths from treatable cancers. All that, and mammograms are notoriously uncomfortable.

“We overspend $4 billion per year on the diagnosis and treatment of cancers that women would never die from,” said Greg Thurber, U-M assistant professor of chemical engineering and biomedical engineering, who led the team. “If we go to molecular imaging, we can see which tumors need to be treated.”
The move could also catch cancers that would have gone undetected. Thurber’s team uses a dye that responds to infrared light to tag a molecule commonly found on tumor cells, in the blood vessels that feed tumors and in inflamed tissue. By providing specific information on the types of molecules on the surface of the tumor cells, physicians can better distinguish a malignant cancer from a benign tumor.
Compared to visible light, infrared light penetrates the body easily—it can get to all depths of the breast without an X-ray’s tiny risk of disrupting DNA and seeding a new tumor. Using a dye delivered orally rather than directly into a vein also improves the safety of screening, as a few patients in 10,000 can have severe reactions to intravenous dyes. These small risks turn out to be significant when tens of millions of women are screened every year in the U.S. alone.
But it’s not easy to design a pill that can carry the dye to the tumor.
“To get a molecule absorbed into the bloodstream, it needs to be small and greasy. But an imaging agent needs to be larger and water-soluble. So you need exact opposite properties,” Thurber said.
Fortunately, they weren’t the only people looking for a molecule that could get from the digestive system to a tumor. The pharmaceutical company Merck was working on a new treatment for cancer and related diseases. They got as far as phase II clinical trials demonstrating its safety, but unfortunately, it wasn’t effective.
“It’s actually based on a failed drug,” Thurber said. “It binds to the target, but it doesn’t do anything, which makes it perfect for imaging.”
The targeting molecule has already been shown to make it through the stomach unscathed, and the liver also gives it a pass, so it can travel through the bloodstream. The team attached a molecule that fluoresces when it is struck with infrared light to this drug. Then, they gave the drug to mice that had breast cancer, and they saw the tumors light up.
The research is described in a study in the journal Molecular Pharmaceutics, titled, “Oral administration and detection of a near-infrared molecular imaging agent in an orthotopic mouse model for breast cancer screening.”
Learn more: Pill for breast cancer diagnosis may outperform mammograms
The Latest on: Breast cancer diagnosis
[google_news title=”” keyword=”breast cancer diagnosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Breast cancer diagnosis
- Author Cathy Kelly rings the ‘chemo bell’ weeks after breast cancer diagnosison December 6, 2023 at 12:52 pm
Author Cathy Kelly has announced that she’s finished her breast cancer treatment after her diagnosis earlier this year.
- Exclusive: Donna Lewis 'Never Meant' to Write About Her Breast Cancer Journey for Her New Album: 'Music Became My Therapy'on December 6, 2023 at 12:32 pm
Donna Lewis took a bit of a hiatus after she was diagnosed with breast cancer in 2021 — the same year she was gearing up to celebrate the 25th anniversary of her hit single "I Love You Always Forever.
- Shannen Doherty admits most harrowing aspect of her stage 4 cancer fighton December 6, 2023 at 12:30 pm
After first being diagnosed with the illness in 2015, Shannen Doherty has admitted she struggled to get out of bed when her weight dropped to 92lbs amid her cancer fight.
- Shannen Doherty Shares the Moment in Her Cancer Journey Where She Feared She ‘Wouldn’t Survive’on December 6, 2023 at 5:48 am
I really learned a lot about myself,” Doherty said about her cancer treatment in new podcast 'Let’s Be Clear with Shannen' ...
- Breast Cancer Canada creates new portal to help those with diagnosison December 6, 2023 at 4:43 am
So the national charity has launched Progress CONNECT, a new portal to help Canadian breast-cancer patients know more about their individual cancer type, options and treatment.
- New Data by Breast Cancer Canada Reveals Almost 3 in 4 Canadians (73%) Turn to Search Engines to Understand a Diagnosis from Their Doctoron December 6, 2023 at 4:00 am
Breast Cancer Canada has launched Progress CONNECT, a new portal equipping Canadian breast cancer patients to know more about their individual cancer type, options and treatment TORONTO — Today, ...
- 70 per cent of Canadians turn to search engines to understand a diagnosis. Here's why that's a problemon December 6, 2023 at 4:00 am
According to new data by Breast Cancer Canada (BCC) released on Wednesday, nearly three in four Canadians (73 per cent) turn to search engines like Google after receiving a diagnosis from their doctor ...
- 'Pink in the Rink' hockey game to honour breast cancer survivoron December 5, 2023 at 2:30 pm
Five years after her initial diagnosis, breast cancer survivor and advocate Andrea Pietramale will drop the puck for special hockey matchup between Superior Heights and Korah ...
- Breast Cancer Survivor: “My Diagnosis is Aggressive, But So Am I”on December 5, 2023 at 2:30 pm
In the face of adversity, breast cancer survivor Ashley Bell emerged as a beacon of hope for those navigating metastatic breast cancer.
via Bing News